MIM
BCYC

Macroview Investment Management’s Bicycle Therapeutics BCYC Stock Holding History

Macroview Investment Management’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-126
Closed -$2.85K – 131
2024
Q3 		$2.85K Hold
126
– – ﹤0.01% 440
2024
Q2 		$2.55K Hold
126
– – ﹤0.01% 464
2024
Q1 		$3.14K Hold
126
– – ﹤0.01% 471
2023
Q4 		$2.28K Sell
126
-209
-62% -$3.46K ﹤0.01% 511
2023
Q3 		$6.73K Buy
+335
New +$7.66K 0.01% 355

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Macroview Investment Management's BCYC Position: Q4 2024 in Review

Macroview Investment Management sold out of Bicycle Therapeutics (BCYC) in Q4 2024, closing a stake of 126 shares — an estimated $2.85K sold.

Macroview Investment Management first reported a position in BCYC in Q3 2023 and held it in 5 quarters. The position peaked at $6.73K in Q3 2023. 97 funds tracked by Wall St. Rank hold BCYC as of Q4 2024.

  • Macroview Investment Management reported no remaining Bicycle Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Macroview Investment Management sold 126 Bicycle Therapeutics shares in Q4 2024, an estimated $2.85K.
  • Macroview Investment Management first reported a position in Bicycle Therapeutics in Q3 2023 and held it in 5 quarters.
  • Macroview Investment Management's Bicycle Therapeutics position peaked at $6.73K in Q3 2023.
  • 97 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q4 2024.

Based on Macroview Investment Management's 13F filing for Q4 2024, filed 31 Jan 2025.